Literature DB >> 24148844

Personalized psychiatry: many questions, fewer answers.

Martin Alda1.   

Abstract

Mesh：

Year:  2013        PMID： 24148844      PMCID： PMC3819149          DOI： 10.1503/jpn.130221

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  15 in total

1.  A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations.

Authors:  J ANGST
Journal:  Psychopharmacologia       Date:  1961-12-19

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  The value of medical spending in the United States, 1960-2000.

Authors:  David M Cutler; Allison B Rosen; Sandeep Vijan
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

4.  Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees.

Authors:  L Franchini; A Serretti; M Gasperini; E Smeraldi
Journal:  J Psychiatr Res       Date:  1998 Sep-Oct       Impact factor: 4.791

5.  Mutation-specific cystic fibrosis treatments on verge of approval.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2011-04       Impact factor: 53.440

6.  Pros and cons of specialised care in bipolar disorder: an international perspective.

Authors:  Eduard Vieta
Journal:  Br J Psychiatry       Date:  2013-03       Impact factor: 9.319

7.  Differentiation of two genetically specific types of depression by the response to antidepressant drugs.

Authors:  C M Pare
Journal:  Humangenetik       Date:  1970

Review 8.  Brain structure and function and the outcomes of treatment for depression.

Authors:  A F Leuchter; I A Cook; S H Uijtdehaage; J Dunkin; R B Lufkin; C Anderson-Hanley; M Abrams; S Rosenberg-Thompson; R O'Hara; S L Simon; S Osato; A Babaie
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

9.  ITAREPS: information technology aided relapse prevention programme in schizophrenia.

Authors:  Filip Spaniel; Pavel Vohlídka; Jan Hrdlicka; Jirí Kozený; Tomás Novák; Lucie Motlová; Jan Cermák; Josef Bednarík; Daniel Novák; Cyril Höschl
Journal:  Schizophr Res       Date:  2007-10-24       Impact factor: 4.939

10.  Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.

Authors:  Julie Garnham; Alana Munro; Claire Slaney; Marsha Macdougall; Michael Passmore; Anne Duffy; Claire O'Donovan; Andrew Teehan; Martin Alda
Journal:  J Affect Disord       Date:  2007-04-17       Impact factor: 4.839
View more
  7 in total

1.  Deconstructing the mental health crisis: 5 uneasy pieces.

Authors:  Zul Merali; Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2016-06       Impact factor: 6.186

Review 2.  Challenges and Future Prospects of Precision Medicine in Psychiatry.

Authors:  Mirko Manchia; Claudia Pisanu; Alessio Squassina; Bernardo Carpiniello
Journal:  Pharmgenomics Pers Med       Date:  2020-04-23

3.  Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept.

Authors:  Leonardo Tondo; Alessandro Miola; Marco Pinna; Martina Contu; Ross J Baldessarini
Journal:  Int J Bipolar Disord       Date:  2022-08-03

4.  Feasibility and acceptability of a novel telepsychiatry-delivered precision prescribing intervention for anxiety and depression.

Authors:  Erin O'Callaghan; Scott Sullivan; Carina Gupta; Heather G Belanger; Mirène Winsberg
Journal:  BMC Psychiatry       Date:  2022-07-19       Impact factor: 4.144

5.  The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders.

Authors:  Anastasia Levchenko; Innokentiy S Losenkov; Natalia M Vyalova; German G Simutkin; Nikolay A Bokhan; Bob Wilffert; Anton Jm Loonen; Svetlana A Ivanova
Journal:  Pharmgenomics Pers Med       Date:  2018-07-20

Review 6.  Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders.

Authors:  Anastasia Levchenko; Timur Nurgaliev; Alexander Kanapin; Anastasia Samsonova; Raul R Gainetdinov
Journal:  Heliyon       Date:  2020-05-20

7.  Investigating aberrantly expressed microRNAs in peripheral blood mononuclear cells from patients with treatment‑resistant schizophrenia using miRNA sequencing and integrated bioinformatics.

Authors:  Xu You; Yunqiao Zhang; Qing Long; Zijun Liu; Xiao Ma; Zixiang Lu; Wei Yang; Ziqiao Feng; Wengyu Zhang; Zhaowei Teng; Yong Zeng
Journal:  Mol Med Rep       Date:  2020-09-15       Impact factor: 2.952
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.